What is the risk of intracerebral hemorrhage after a fall in an elderly patient taking aspirin?

Risk of Intracerebral Hemorrhage After Fall in Elderly on Aspirin

Elderly patients (≥65 years) on aspirin who fall and sustain mild head trauma have approximately a 4% risk of delayed intracerebral hemorrhage, with clinically significant outcomes (requiring neurosurgery or death) occurring in about 1-2% of cases. 1

Evidence-Based Risk Assessment

The 2023 ACEP Clinical Policy provides the most comprehensive guidance on this specific population 1. In a study of 100 elderly patients (≥65 years) on low-dose aspirin with isolated mild head injury (GCS 15) and initial negative head CT:

• 4% developed delayed ICH
• 1% required neurosurgical decompression
• 1% died

This contrasts with lower rates seen in patients on anticoagulants alone (0.6-1.5% delayed ICH rate), suggesting aspirin may confer unique risk in the elderly trauma population.

Clinical Management Algorithm

Initial Assessment

For elderly patients on aspirin presenting after a fall:

1. Obtain head CT immediately if any of the following are present:

   • Loss of consciousness
   • Posttraumatic amnesia
   • GCS < 15
   • Focal neurological findings
   • External signs of head trauma (scalp laceration, bruising)

2. If initial CT is negative and patient is neurologically intact:

   • The 2023 ACEP guideline advocates for longer observation and/or repeat imaging specifically for elderly patients on aspirin 1
   • This is a more cautious approach than for patients on other antiplatelet agents (clopidogrel) or even some anticoagulants

Risk Stratification

Higher risk patients requiring extended monitoring:

• Age ≥ 65 years on aspirin
• GCS < 15 at presentation
• Loss of consciousness or amnesia
• Dual antiplatelet therapy (aspirin + clopidogrel)
• Concurrent anticoagulant use 2

Lower risk (but not zero risk):

• GCS 15 throughout
• No loss of consciousness
• No amnesia
• Aspirin monotherapy

Important Caveats and Pitfalls

The Aspirin Data Gap

Critical limitation: The ACEP guideline explicitly states that "the main exclusion from this clinical policy recommendation is the concomitant use of aspirin; there were not enough cases to make a recommendation for that particular antiplatelet agent" 1. The evidence base for aspirin is substantially weaker than for warfarin, NOACs, or clopidogrel.

Delayed Hemorrhage Timing

Most delayed ICH occurs within 24 hours, but cases have been reported up to 8 days post-injury 1. The single study death in the NOAC population occurred at day 8, emphasizing the importance of clear discharge instructions.

Comparison to Other Antithrombotics

The risk profile differs by agent:

• Warfarin: 0.6% delayed ICH rate (Class II evidence) 1
• Clopidogrel: 0% delayed ICH in one major study 1
• NOACs: 1.5% delayed ICH rate 1
• Aspirin (elderly): 4% delayed ICH rate 1

Age-Specific Considerations

The increased risk in elderly aspirin users may relate to:

• Higher prevalence of cerebral amyloid angiopathy
• Increased cerebral small vessel disease
• Altered platelet function with aging
• Concurrent comorbidities

Notably, one study found aspirin to be "protective" against ICH in elderly fallers 3, but this contradicts the higher-quality prospective data and likely reflects selection bias in the retrospective design.

Discharge Recommendations

If discharging after negative initial CT:

• Provide explicit return precautions for:

  • Worsening headache
  • Confusion or altered mental status
  • Focal weakness or numbness
  • Seizures
  • Persistent vomiting
  • Loss of consciousness

• Do not routinely discontinue aspirin unless patient is supratherapeutic or has other bleeding concerns 1. The low incidence of delayed ICH does not justify withholding cardiovascular protection, particularly for secondary prevention where aspirin benefit far exceeds risk 4, 5.

• Consider social support and fall risk when deciding on observation vs. discharge

Bleeding Risk Context

The FDA label warns that aspirin increases stomach bleeding risk, particularly in those ≥60 years with history of ulcers, on anticoagulants, or consuming ≥3 alcoholic drinks daily 6. This systemic bleeding risk extends to intracranial hemorrhage in the trauma setting, though the absolute risk remains relatively low at 4% for delayed ICH.

For patients with established cardiovascular disease, aspirin for secondary prevention remains strongly indicated 4, 5, and the trauma-related ICH risk should not automatically prompt discontinuation unless bleeding occurs.